Immunovaccine Technologies Inc.
Records under this name other than patents Immunovaccine Technologies Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Immunovaccine Technologies Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,232,052 | Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase for Delivery of Polynucleotides in Vivo Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,717,563 | Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,729,766 | Method for Improving the Efficacy of a Survivin Vaccine in the Treatment of Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 10,533,033 | Lipid a Mimics, Methods of Preparation, and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,042,537 | Methods of Using Low Dose Volume B-Cell Epitope Compositions for Inducing an Antibody Immune Response in Human Subjects Formerly held In force · High confidence | In force | High confidence | |
| US 10,105,435 | Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof Formerly held Lapsed on the fee record Ended Oct 23, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 23, 2026 | Low confidence |
| US 10,272,042 | Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment Formerly held Term ended Term ended Oct 5, 2026 · Medium confidence | Term ended | Term ended Oct 5, 2026 | Medium confidence |
| US 11,406,705 | Methods of Using Low Dose Volume B-cell Epitope Compositions for Inducing an Antibody Immune Response in Human Subjects Formerly held Lapsed on the fee record Ended Aug 9, 2026 · High confidence | Lapsed on the fee record | Ended Aug 9, 2026 | High confidence |
| US 10,022,441 | Method for Improving the Efficacy of a Survivin Vaccine in the Treatment of Cancer Formerly held Lapsed on the fee record Ended Jul 17, 2026 · High confidence | Lapsed on the fee record | Ended Jul 17, 2026 | High confidence |
| US 9,925,142 | Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment Formerly held Lapsed on the fee record Ended Mar 27, 2026 · Low confidence | Lapsed on the fee record | Ended Mar 27, 2026 | Low confidence |